Stocks
Arcutis Biotherapeutics (ARQT) EBITDA US GAAP (year values) |
||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | |||
| EBITDA, bln rub | ? | -205.6 | -294.6 | -227.4 | -109.6 | 2.48 | 12.8 | |
| Changes by years, y/y, % | +52% | +43% | -23% | -52% | -102% | |||
Arcutis Biotherapeutics. EBITDA US GAAP, bln rub
Arcutis Biotherapeutics. EBITDA US GAAP, changes, %
Arcutis Biotherapeutics. EBITDA US GAAP, sum by quarters, bln rub
Arcutis Biotherapeutics (ARQT) EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EBITDA, bln rub | ? | -18.7 | -12.0 | 11.1 | 22.1 | -6.27 | 12.8 | |
| Changes by years, y/y, % | -31% | -73% | -133% | -597% | -66% | |||
| Changes by quarters, q/q, % | +319% | -36% | -193% | +99% | -128% | |||
